536 related articles for article (PubMed ID: 19892433)
1. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
2. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab in a patient with neovascular glaucoma.
Kahook MY; Schuman JS; Noecker RJ
Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
6. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab as adjuvant for neovascular glaucoma.
Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
Kitnarong N; Chindasub P; Metheetrairut A
Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
Wasik A; Song HF; Grimes A; Engelke C; Thomas A
Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Yazdani S; Hendi K; Pakravan M
J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
[TBL] [Abstract][Full Text] [Related]
11. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
Fong AW; Lee GA; O'Rourke P; Thomas R
Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
Vatavuk Z; Bencic G; Mandic Z
Eur J Ophthalmol; 2007; 17(2):269-71. PubMed ID: 17415704
[TBL] [Abstract][Full Text] [Related]
13. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
[TBL] [Abstract][Full Text] [Related]
14. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
Ouhadj O; Chergui I; Mendil L; Nouri MT
J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
[TBL] [Abstract][Full Text] [Related]
15. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
17. Intracameral bevacizumab for iris rubeosis.
Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
[TBL] [Abstract][Full Text] [Related]
20. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]